Breast Cancer

Article	Citations
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	144
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	55
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	45
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	40
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	33
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy	31
Low-carbohydrate diet score and risk of breast cancer: findings from a prospective cohort study	28
Prognostic model for pulmonary metastasis in patients with HER2-positive breast cancer: a population-based study	26
Changes in re-excision rates after publication of guidelines defining positive margins for breast-conserving surgery: a collaborative study of the Japanese breast cancer society	21
Factors associated with post acute care utilization after mastectomy for breast cancer patients	20
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances	20
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions — a first large-scale multi-institutional clinical trial in Japan	20
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan	19
Emerging roles of KIR2DL4 in cancer immunotherapy	19
The role of C1orf50 in breast cancer progression and prognosis	19
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	19
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	18
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	18
Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial	18
Real-world analysis of interstitial lung disease/pneumonitis in Japanese patients with breast cancer receiving trastuzumab deruxtecan	17
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study	17
Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score® test among node-negative early breast cancer patients in Japan	17
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	17
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	16
Exploring a specialized lactylation pattern to predict the prognosis and sensitivity of immunotherapy in breast cancer via machine learning	16

Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival	16
Prospective randomized-controlled trial: efficacy of 37 °C-preheated thermoplastic elastomer (TPE) bolus in postoperative radiotherapy for breast cancer patients	15
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	15
Low-progesterone receptor expression predicts nodal pathological complete response after neoadjuvant chemotherapy in premenopausal patients with ER-positive/HER2-negative breast cancer	15
Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutio	15
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan	14
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	14
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	14
Safety of radiotherapy in patients undergoing breast reconstruction based on patient-reported outcomes: a multicenter collaborative study	14
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer	14
Comparative evaluation of treatment recommendations generated by generative AI and breast cancer specialists for advanced and recurrent breast cancer: a multidimensional assessment of evidence interpr	13
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	13
Glutaminase (GLS1) gene expression in primary breast cancer	13
SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	13
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	13
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	13
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	12
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	12
Evaluation of serum microRNA-9-5p expression and its predicted target genes as potential biomarkers for breast cancer	12
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a	12
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer	12
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	12
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer	12
CT findings of lung injury during breast cancer treatment	11
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy	11
Comparison of three arm-positioning techniques for minimizing motion artifacts in breast magnetic resonance imaging: a prospective volunteer study	11
Chemotherapy and cognition: a promising start, but mechanistic clarity still needed	11
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	11
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2− advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis	11
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer	11
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	11
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol	11
An investigation to identify the factors for negative sentinel lymph node metastasis in early breast cancer cases	10
Breast cancer screening guidelines: discrepancies raise concerns about validity	10
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status	10
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017	10
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis	10
Impact of artificial intelligence in breast cancer screening with mammography	10
Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions	10
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein	10
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	10
Clinical outcomes of postoperative radiotherapy with regional nodal irradiation excluding internal mammary lymph nodes in breast cancer: a multi-institutional retrospective analysis	10
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study	10
Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer	10
Association between preoperative grip strength and postoperative upper extremity impairments in patients with breast cancer: a retrospective cohort study	10
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models	9
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)	9
Early outcomes of accelerated partial breast irradiation and dosimetric comparison of volumetric modulated arc therapy and three-dimensional conformal radiotherapy	9
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	9
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes	9

Color differences of skin paddles using the free flap for autologous breast reconstruction in Asian patients	9
Breast reconstruction-related complications from postmastectomy radiation therapy in stage II–III breast cancer: sub-analysis of a multi-institutional observational study (Reborn-03)	9
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	9
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast	9
Correction: The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathway	8
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	8
HER2-positive apocrine carcinoma of the breast and PIK3CA mutations	8
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	8
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	8
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	8
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	8
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	8
The impact of specialist palliative care on healthcare utilization among patients with breast cancer: a nationwide register-based cohort study	8
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells	8
Evaluating high-risk breast cancer surveillance outcomes in BRCA mutation carriers	8
Performance analysis of screening mammography in Asian women under 40 years	8
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	8
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes	8
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	8
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen r	8
Patient satisfaction on prescription refill systems for breast cancer patients in Japan using a digital self-administered survey	8
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity	8
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	7
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	7
Response to letter to the editor: Risk of endometrial cancer among breast cancer survivors in Japan—a matched cohort study	7
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	7
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort study	7
Management of nausea and vomiting induced by antibody–drug conjugates	7
Efficacy and prognostic predictors of primary systemic therapy for de novo Stage IV breast cancer. Exploratory analysis of JCOG1017 PRIM-BC	7
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	7
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	7
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	7
Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02)	7
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	7
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	6
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	6
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	6
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	6
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	6
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	6
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	6
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	6
Timing of postmastectomy radiation therapy in two-stage expander/implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese breast cancer society clinical practic	6
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	6
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	6
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	6
Characterization of gut microbiota dysbiosis in breast cancer patients	6
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	6
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	6
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	6
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women	6
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	6
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	6
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	6
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	6
Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer	6
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	6
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis	6
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	6
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	6
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor reg	5
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer	5
Prospective study of once-daily accelerated partial breast irradiation using 3-dimensional conformal external beam radiotherapy for Japanese women: 12-year outcomes, toxicity, and cosmesis	5
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study	5
Breast cancer screening rates and influencing factors among LGBTQ groups in Japan	5
Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?	5
Time-dependent diffusion MRI for non-invasive differentiation of benign and malignant breast lesions and evaluation of proliferation index biomarkers	5
Cost-effectiveness of clinical breast examination screening programme among HER2-positive breast cancer patients: a modelling study	5
Effects of CBT-based interventions on health outcomes in breast cancer patients: a systematic review and Meta-analysis	5
Real world experience of intraoperative radiation therapy (IORT) during lumpectomy for early-stage breast cancer: retrospective data from a single large institutional observational study	5
Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM)	5
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients	5
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses	5
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies	5
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer	5
Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery	5
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	5
Impact of community-based exercise on fatigue in early breast cancer survivors: identifying potential determinants of change	5
Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study	5

Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer	5
Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients	5
Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price	5
KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog signaling pathway	5
Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer	4
Treatment and prognosis of patients with hormone receptor-low positive (1%–10%) breast cancer: a retrospective propensity score-matched analysis	4
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database	4
Acknowledgments to reviewers 2023	4
Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study	4
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy	4
Endometrial cancer after breast cancer: caution in interpretation of risk estimates	4
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients	4
C-type lectin-like domain family 2 (CLEC2D) promotes proliferation and migration of breast cancer and serves as a poor prognostic factor	4
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer	4
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer	4
Prognostic and monitoring value of circulating tumor DNA at multiple clinical time points in breast cancer	4
Validation of the postoperative prognostication tool PREDICT version 2.2 and 3.0 using data from the National cancer center hospital in Japan	4
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female	4
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a mu	4
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study	4
Acknowledgments to reviewers 2022	4
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer	4
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community	4
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan	4
Major anatomic variations of the lateral upper arm lymphatic pathway in a healthy female population	4
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole	4
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer	4
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study	4
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor–	3
Reply to the Letter to the editor “Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?”	3
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry	3
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype	3
Dietary intake of branched-chain amino acids in relation to the risk of breast cancer	3
Impact of modified dexamethasone administration sequence on infusion reaction incidence in HER2-positive breast cancer: a randomized multicenter trial	3
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case–control study of abemaciclib-induced interstitial lung disease (NOSIDE)	3
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study	3
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer	3
Key issues in surveillance of secondary breast cancer	3
Wrapping up the evidence: bandaging in breast cancer-related lymphedema—a systematic review and meta-analysis	3
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy	3
Antipsychotic therapy and breast cancer risk: a comprehensive systematic review and meta-analysis	3
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy	3
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry	3
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer	3
Targeting breast cancer senescence in 3D models of bone metastasis	3
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	3
Association of adiponectin gene polymorphism with adipokine and lipid profile in breast cancer patients from Kano, Nigeria	3
Long-term outcomes of adjuvant radiation in elderly Asians with early stage IIA breast cancer after breast-conserving surgery: a population-based study	3
Investigating the shared genetic architecture and causality of breast cancer and thyroid cancer: genome-wide cross trait analysis and bi-directional Mendelian randomization study	3
Adjuvant radiotherapy and survival in patients with malignant phyllode tumors: a population-based retrospective study	3
miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway	3
Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study	3
Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)	3
Causes of varied internal echo patterns in ultrasound imaging of breast lymphoma	3
French national survey on breast cancer care: caregiver and patient views	3
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy	3
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1	3
Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer	3
Macroscopic morphology of breast carcinoma: associations with biological subtypes and pathological features	3
tRNA modification genes are associated with genomic instability, proliferative programs, and poor prognosis in breast cancer	3
"Safety and efficacy of early drain removal in breast reconstruction: a retrospective cohort study"	3
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world	3
Neurospora crassa is a potential source of anti-cancer agents against breast cancer	3
Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial	3
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images	3
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies	3
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro	3
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)	3
Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis	2
Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study	2
Overall survival of patients with second primary breast cancer associated with molecular subtype and epidemiological profile at a cancer center	2
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients	2
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort	2
Evaluating the quality of Japanese YouTube videos on breast cancer treatment using PRHISM: comparison by source credibility	2
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review	2
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan	2
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre	2
Postoperative complications following prepectoral versus subpectoral tissue expander placement in immediate breast reconstruction: a retrospective study from Japan	2
Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants	2
Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer	2
Risk of endometrial cancer among breast cancer survivors in Japan: a matched cohort study	2
Artificial intelligence computer-aided detection enhances synthesized mammograms: comparison with original digital mammograms alone and in combination with tomosynthesis images in an experimental sett	2
Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2− advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-	2
Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing	2
Clinical application of 90-gene expression test in a patient with occult breast cancer: a case report and literature review	2
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer	2
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression	2
Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancer	2
Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancer	2
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry	2
Presenteeism in working-age breast cancer survivors 1–5 years after surgery: relative contributions of treatment-related symptoms and modifiable factors	2
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?	2
Conservative axillary surgery is emerging in the surgical management of breast cancer	2
Advances in the study of autophagy in breast cancer	2
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors	2